BRITTANY LINN: Open Payments
NPI 1356936082 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,041 in 49 payments from 17 companies in 2025. Trend: 2023 $2,083 · 2024 $2,087 · 2025 $1,041
Food & beverage: $1,041
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 14 | $209 |
| AstraZeneca Pharmaceuticals LP | 5 | $148 |
| Viatris Specialty LLC | 4 | $118 |
| Axsome Therapeutics, Inc. | 3 | $71 |
| United Therapeutics Corporation | 3 | $67 |
| Genentech USA, Inc. | 4 | $65 |
| Grifols USA, LLC | 2 | $55 |
| Novo Nordisk Inc | 3 | $53 |
| Amgen Inc. | 2 | $44 |
| Verona Pharma, Inc. | 2 | $40 |
Products named: FASENRA, TRELEGY ELLIPTA, YUPELRI, NUCALA, Sunosi, Tyvaso, Xolair, TEZSPIRE.
Industry payments across KY — which companies pay providers there.
